Physicochemical and colon cancer HT-29 cell inhibitory property of homogeneous polysaccharide from Stropharia rugosoannulata

Int J Biol Macromol. 2025 May;307(Pt 2):141975. doi: 10.1016/j.ijbiomac.2025.141975. Epub 2025 Mar 11.

Abstract

The development of active polysaccharides from edible mushrooms for antitumor drugs or functional foods has become a research hotspot. In this study, the physicochemical properties and monosaccharide composition of four homogeneous polysaccharides (CASP-0, CASP-1, CASP-2 and CASP-3) purified from alkali-extracted Stropharia rugosoannulata polysaccharides by DEAE-52 column were investigated, and the inhibitory effect against colon cancer HT-29 cell in vitro were explored. Results showed that four polysaccharides were homogeneous with molecular weights of 84.8 KDa (CASP-0), 11.1 KDa (CASP-1), 58.6 KDa (CASP-2) and 97.8 KDa (CASP-3). CASP-0 and CASP-3 contained glucose, mannose and galactose in molar ratios of 83.76:13.96:2.27 and 89.72:4.68:5.59, while CASP-1 and CASP-2 contained glucan. The four polysaccharides significantly reduced the cell viability of HT-29 cell in dose-dependent and time-dependent manner. With the increase of polysaccharide concentration, CASPs significantly inhibited the migration and invasion of HT-29 cell. The four polysaccharides induced HT-29 cell apoptosis by up-regulating the expression of Caspase-3 and Bax protein, and down-regulating the expression of Bcl-2 protein, suggesting that HT-29 cell apoptosis may be a mitochondria-mediated pathway. This study provides a theoretical basis for the potential application in medicine and functional food.

Keywords: Antitumor; HT-29 cell; Physicochemical property; Polysaccharide; Stropharia rugosoannulata.

MeSH terms

  • Agaricales* / chemistry
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Apoptosis / drug effects
  • Caspase 3 / metabolism
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Chemical Phenomena*
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / metabolism
  • Colonic Neoplasms* / pathology
  • Fungal Polysaccharides* / chemistry
  • Fungal Polysaccharides* / pharmacology
  • HT29 Cells
  • Humans
  • Molecular Weight
  • Monosaccharides / analysis
  • Polysaccharides* / chemistry
  • Polysaccharides* / pharmacology

Substances

  • Polysaccharides
  • Antineoplastic Agents
  • Fungal Polysaccharides
  • Caspase 3
  • Monosaccharides